KDA Group

KDA Group Operating Cash Flow

The Operating Cash Flow of KDA Group (KDA.V) as of Nov 12, 2026 is -2.36 M CAD. In the previous year, Operating Cash Flow was -1.89 M CAD — a change of 25.19% (lower).

Operating Cash Flow

-2.36 MCAD

YoY

25.19%

Last updated:

Operating Cash Flow of KDA Group is 2025 -2.36 M CAD. Operating Cash Flow of KDA Group was 2024 -1.89 M CAD. It decreases by 25.19% lower compared to the previous year.

The KDA Group Operating Cash Flow history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Operating Cash Flow
Date
Operating Cash Flow
Jan 1, 2018
764,865.00 CAD
Jan 1, 2019
-2.35 M CAD
Jan 1, 2020
-1.42 M CAD
Jan 1, 2021
2.94 M CAD
Jan 1, 2022
1.42 M CAD
Jan 1, 2023
-844,018.00 CAD
Jan 1, 2024
-1.89 M CAD
Jan 1, 2025
-2.36 M CAD
The KDA Group Operating Cash Flow history
YEAROperating Cash FlowYoY
-2.36 MCAD+25.19%
-1.89 MCAD+123.76%
-844,018.00CAD-159.58%
1.42 MCAD-51.87%
2.94 MCAD-307.72%
-1.42 MCAD-39.73%
-2.35 MCAD-407.39%
764,865.00CAD-149.50%
-1.55 MCAD+72.05%
-898,189.37CAD-2.87%
-924,714.15CAD-241.71%
652,534.96CAD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

KDA Group Stock analysis

What does KDA Group do? KDA Group, Inc. generates revenue through its Pharmacy Services, Pharmaceutical Solutions, and Pharmaceutical Technology segments. The Pharmacy Services segment provides training, consulting, and replacement services for healthcare professionals. The Pharmaceutical Solutions segment develops and integrates technological platforms for healthcare professionals. The Pharmaceutical Technology segment offers KRX, KRX DENTAL, and ADRX platforms, while ZRx Digital Prescriber is an electronic prescriber software for authorized healthcare providers. Subsidiaries like Alliance Pharma Operations Inc. and Elitis Pharma Inc. support these services. Clients include healthcare professionals who require training, consulting, and technological solutions. The Pharmacy Services segment targets professional resource needs in healthcare, while Pharmaceutical Solutions and Technology segments serve healthcare professionals with integrated platforms and digital tools. Subsidiaries such as Logistik Pharma Inc. and Groupe Technologique KDA Inc. contribute to the company's service delivery. Pharmaceutical Technology platforms like KRX, KRX DENTAL, and ADRX are sold to healthcare professionals seeking digital solutions. ZRx Digital Prescriber is utilized by authorized prescribers for medication and treatment management. The company's subsidiaries operate within the segments to deliver specialized services, ensuring comprehensive solutions for healthcare providers. KDA Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about KDA Group stock

Operating Cash Flow of KDA Group is -2.36 M CAD in 2025.

Operating Cash Flow of KDA Group changed from -1.89 M CAD to -2.36 M CAD, representing a 25.19% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow KDA Group since 2006 – with annual values, charts, and detailed analysis.

Operating cash flow measures the cash generated from core business operations. It is a pure measure of a company's ability to generate cash.

Operating Cash Flow's CAD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Operating Cash Flow's KDA Group historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — KDA Group

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — KDA Group